SCHEMBL15039793

SCHEMBL15039793

Cc1ccc(NC2=CC(=O)C(Nc3ccc(O)c(Cl)c3)=C/C2=N/c2ccc(O)c(Cl)c2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DNM1 Q05193 1/20 0.40
▸ L3MBTL1 Q9Y468 4/20 0.36
▸ BLM P54132 2/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ LMNA P02545 2/20 0.36
▸ MAPT P10636 2/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ TDP2 O95551 1/20 0.36
▸ NSD2 O96028 1/20 0.36
▸ TP53 P04637 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ CASP3 P42574 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ SENP8 Q96LD8 1/20 0.36
▸ SENP7 Q9BQF6 1/20 0.36
▸ SENP6 Q9GZR1 1/20 0.36
▸ APAF1 O14727 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15020067 0.93 DNM1 (0.42) DNM1BLMALDH1A1LMNAMAPT
SCHEMBL15020065 0.93 DNM1 (0.42) DNM1BLMALDH1A1LMNAMAPT
SCHEMBL15039580 0.93 DNM1 (0.42) DNM1BLMALDH1A1LMNAMAPT
SCHEMBL15039543 0.90 DNM1 (0.40) DNM1L3MBTL1BLMALDH1A1LMNA
SCHEMBL15039585 0.86 MAPK14 (0.41) DNM1BLMALDH1A1LMNAMAPT
SCHEMBL15020488 0.85 DNM1 (0.38) DNM1BLMALDH1A1LMNAMAPT
SCHEMBL15020486 0.85 DNM1 (0.38) DNM1BLMALDH1A1LMNAMAPT
SCHEMBL16426675 0.85 DNM1 (0.38) DNM1BLMALDH1A1LMNAMAPT
SCHEMBL15039790 0.84 DNM1 (0.49) DNM1L3MBTL1BLMALDH1A1LMNA
SCHEMBL15019821 0.84 TXNRD1 (0.35) L3MBTL1BLMALDH1A1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9554977-B2 Triaromatic azomethine direct dyes, dye composition comprising at least one such dye, method of implementation and use L'OREAL (FR) 2017-01-31 — — US disclosed
US-20150320660-A1 TRIAROMATIC AZOMETHINE DIRECT DYES, DYE COMPOSITION COMPRISING AT LEAST ONE SUCH DYE, METHOD OF IMPLEMENTATION AND USE L'OREAL (FR) 2015-11-12 — — US disclosed
WO-2013087768-A1 TRIAROMATIC AZOMETHINE DIRECT DYES, DYE COMPOSITION COMPRISING AT LEAST ONE SUCH DYE, METHOD OF IMPLEMENTATION AND USE L'OREAL (FR) 2013-06-20 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150320660-A1 TRIAROMATIC AZOMETHINE DIRECT DYES, DYE COMPOSITION COMPRISING AT LEAST ONE SUCH DYE, METHOD OF IMPLEMENTATION AND USE KRT18, MKI67, CDC73 DNM1 2808/4885L3MBTL1 4870/4885BLM 3275/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback